Medical experts are developing a spray that could help control the corona virus, with results that have been encouraging to animals so far.
Vaccines are being developed around the world to prevent the corona virus, but other sources are being tested by Australian scientists.
A molecule similar to this drug by Australian researchers could be used as a nasal spray, the results of which have been released.
According to these results, this spray activates the body’s natural immune system by connecting with the cells of the nostrils.
The immune response to vaccines triggers antibodies and T cells against a specific bacterium, but the natural immune system works against a wide variety of germs.
Experts from a biotech company called Anna Receptri are working on the spray, which acts as a protective shield.
Read More:India claims availability of corona vaccine early next year
According to experts, spray Anna 051 activates the natural immune system which prevents the virus from copying inside the cells.
The results of this study have not yet been published in any medical journal and the researchers said that the spray was used in different amounts on the noses of 3 groups of animals called ferrites.
Each group had 6 ferrets and a fourth group was given a placebo instead of a spray.
Five days later, the animals were infected with the corona virus and it was discovered that those who were sprayed had 96% less viral RNA or the genetic material of the virus than in the fourth group.
It is yet to be tested on humans to see if it is effective and safe against the virus in humans.
According to experts, the spray containing Anna 051 can be used twice a week as a precautionary measure.
Especially for people who are at high risk for the corona virus.
Read More:Pakistan launches third phase of corona virus vaccine trial
Experts say that this is expected to help reduce the severity and duration of the virus-borne disease Code 19, while also reducing the number of viral particles in the nose.
He added that this could lead to the transmission of the virus from one person to another, but further research is needed to make a final decision.